Monroe Terilyn J. sold $7.6M of GH
Monroe Terilyn J. (Chief People Officer) sold 46,300 shares of Guardant Health, Inc. (GH) at an average of $165.12 ($163.41–$167.92, $7.65M total) across 5 trades on 2026-08-12.
How this was made
The 30-second read
Why it matters
The newest disclosed fact is the open-market sale of 46,300 shares across five trades at an average price of about $165.12, totaling about $7.65M, with holdings after the sale of 22,979 shares.
Market read
Traders may monitor for follow-on insider activity, but the filing alone does not change Guardant’s fundamentals.
What to watch
Insider sales can be driven by diversification, taxes, or pre-scheduled personal liquidity needs; without additional context, the signal is weak.
Background
This is an SEC Form 4 insider transaction for Guardant Health, Inc. (GH) by Chief People Officer Monroe Terilyn J.
Ticker impact
Guardant Health insider Monroe Terilyn J. sold about $7.65M of GH shares in open-market trades on 2026-08-12.
Likely limited near-term impact; any reaction would be sentiment-driven rather than fundamentals.
Form 4 insider sales are common and often non-informational; the article provides transaction size and timing but no accompanying company news or guidance change.
Market effects
Minimal, as this is company-specific insider trading with no sector-wide catalyst.
None indicated.
None indicated.
Counterpoint
The absence of a disclosed 10b5-1 plan could be interpreted by some traders as higher signaling risk, potentially increasing short-term sensitivity to further insider activity.
Key entities
- issuerGuardant Health, Inc.
Company whose shares were sold by an insider in the reported Form 4.
- insiderMonroe Terilyn J.
Chief People Officer who executed the open-market sale.
